Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Judy E. Garber, MD, MPH
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
- Mountain Blue Cancer Care Center - Swedish
Englewood, Colorado, United States
- Rocky Mountain Cancer Centers - Swedish
Englewood, Colorado, United States
- Rocky Mountain Cancer Centers-Littleton
Littleton, Colorado, United States
- Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree, Colorado, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Northshore University Healthsystem-Highland Park Hospital
Highland Park, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- University of Kansas Hospital-Indian Creek Campus
Overland Park, Kansas, United States
- University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas, United States
- Maine Medical Center- Scarborough Campus
Scarborough, Maine, United States
- Maine Medical Partners - South Portland
South Portland, Maine, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids, Michigan, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Regions Hospital
Saint Paul, Minnesota, United States
- Optumcare Cancer Care at Fort Apache
Las Vegas, Nevada, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Novant Health Presbyterian Medical Center
Charlotte, North Carolina, United States
- Novant Health Breast Surgery - Greensboro
Greensboro, North Carolina, United States
- Novant Health Cancer Institute - Kernersville
Kernersville, North Carolina, United States
- Novant Health Cancer Institute - Mount Airy
Mount Airy, North Carolina, United States
- Novant Health Cancer Institute - Thomasville
Thomasville, North Carolina, United States
- Novant Health Forsyth Medical Center
Winston-Salem, North Carolina, United States
- Sanford Roger Maris Cancer Center
Fargo, North Dakota, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Feb 2023
- Primary completion
- 31 Jul 2027
- Completion
- 31 Dec 2033
- Last update posted
- 2 Apr 2025
- Registered enrollment
- 300
- Registry id
- NCT04711109
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.